We market well.
Your agency should fully understand your product and the science. Then, there’s the marketplace. Grasping all three dynamics is a specialized field. Ours.
Our philosophy implies there are no excuses for boring and dull. The medical industry deserves better.
Spread the word. Big or small. Any time, any place. Right now, today. Don’t wait, hesitate or ruminate. We can help all medical companies. We’d like to make your brand our next success story.
NOW IN PROGRESS
World’s 2nd most popular
search engine? YouTube.
People are naturally interested in other humans and information.
Attract, educate and engage with videos that tell your story—just keep it brief.
recent work right here
WASHINGTON (Reuters) - U.S. House leaders have decided against holding a vote on a reworked healthcare system overhaul this week after failing to find the necessary support, congressional aides said on Thursday.... (Reuters Health) – Even as doctors are increasingly relying on home blood pressure monitoring to manage patients with hypertension, many of the devices are too inaccurate to be useful, according to a small study.... NEW YORK (Reuters) - Health insurers seeking regulatory approval for 2018 individual insurance plans can file two sets of premium rates as a way to deal with market uncertainty created by Republicans' promise to repeal and replace Obamacare, a California state insurance regulator said on Friday.... (Reuters) - Japan's Takeda Pharmaceutical Co Ltd said on Friday that the U.S. Food and Drug Administration approved its lung cancer drug, almost three months after the company acquired the drug's developer, Ariad Pharmaceuticals Inc.... (Reuters Health) - U.S. public health officials declared victory over malaria in 1951, but the mosquito-borne disease continues to infect and kill American travelers, a new study shows.... (Reuters) - The U.S. Food and Drug Administration approved Novartis AG's Rydapt as an initial treatment for acute myeloid leukemia (AML) as well as certain other blood disorders, the agency said on Friday.... MEXICO CITY (Reuters) - Mexico's Lower House of Congress passed a bill on Friday to legalize the use of marijuana and cannabis for medical and scientific needs, a step closer to outright legalization in a country long scarred by warring drug cartels.... (Reuters) - The U.S. Food and Drug Administration on Friday approved Radius Health Inc's drug to treat osteoporosis in postmenopausal women at high risk of fracture or those who have failed other therapies.... (Reuters Health) - Having a family history of prostate cancer doesn’t make it more risky for men with a new diagnosis of the disease to initially hold off on active treatment in favor of monitoring with periodic lab tests, a research review suggests.... (Reuters Health) - Instead of eating less saturated fat and worrying about so-called bad cholesterol, a group of doctors suggests an alternative approach for preventing heart disease....